Your browser doesn't support javascript.
loading
A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD.
Tse, Gary; Emmanuel, Benjamin; Ariti, Cono; Bafadhel, Mona; Papi, Alberto; Carter, Victoria; Zhou, Jiandong; Skinner, Derek; Xu, Xiao; Müllerová, Hana; Price, David.
Afiliación
  • Tse G; Observational and Pragmatic Research Institute, Singapore, Singapore.
  • Emmanuel B; School of Nursing and Health Studies, Hong Kong Metropolitan University, Hong Kong, People's Republic of China.
  • Ariti C; AstraZeneca, Gaithersburg, MD, USA.
  • Bafadhel M; Observational and Pragmatic Research Institute, Singapore, Singapore.
  • Papi A; Department of Immunobiology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Carter V; Respiratory Medicine, Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
  • Zhou J; Observational and Pragmatic Research Institute, Singapore, Singapore.
  • Skinner D; Observational and Pragmatic Research Institute, Singapore, Singapore.
  • Xu X; Observational and Pragmatic Research Institute, Singapore, Singapore.
  • Müllerová H; AstraZeneca, Gaithersburg, MD, USA.
  • Price D; AstraZeneca, Cambridge, UK.
Int J Chron Obstruct Pulmon Dis ; 18: 2565-2580, 2023.
Article en En | MEDLINE | ID: mdl-38022830
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos Cerebrovasculares / Enfermedad Pulmonar Obstructiva Crónica / Diabetes Mellitus Tipo 2 Límite: Humans Idioma: En Revista: Int J Chron Obstruct Pulmon Dis Año: 2023 Tipo del documento: Article País de afiliación: Singapur
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos Cerebrovasculares / Enfermedad Pulmonar Obstructiva Crónica / Diabetes Mellitus Tipo 2 Límite: Humans Idioma: En Revista: Int J Chron Obstruct Pulmon Dis Año: 2023 Tipo del documento: Article País de afiliación: Singapur